Ysios Capital
Venture capitalDenmark · Series A–Late Stage · 24 people tracked
Investment thesis
Ysios Capital invests in biotech ventures focused on bringing life-changing treatments to patients, particularly for indications with high unmet medical need. The firm prioritizes exceptional management teams combined with pioneering science, seeking to transform capital into medical breakthroughs. The investment approach emphasizes asset-centric companies and product-enabling platform technologies with proprietary products that advance therapeutic innovation.
Source: firm website, verified Jul 21, 2026.
Team · 24 people
from the firm's websiteWhat they invest in
from 11 of 51 portfolio companiesBiotech ×9Healthtech ×6Medical Devices ×6Digital Health ×5AI & Machine Learning ×1Cloud Computing ×1Cybersecurity ×1Deep Tech ×1
HQs:Denmark×2United States×2Spain×1France×1Japan×1Netherlands×1
Investments · 51 tracked
founders shown can be your intro pathSpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.
BiotechDigital HealthMedical Devices<UNKNOWN>, DK
Babyscripts provides remote patient monitoring and care management software for obstetric teams to identify maternal health risks during pregnancy and postpartum, serving health systems, private practices, and payers.
Digital HealthFemTechHealthtech
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses. The company operates globally with manufacturing facilities across the United States, Europe, and Asia, serving patients and healthcare providers worldwide.
BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
William K. BowesGeorge B. Rathmann(First CEO)
Check Point delivers unified security solutions for artificial intelligence, infrastructure, data, and users across on-premises, cloud, and hybrid environments. The company provides zero-trust network security, workspace protection, and real-time threat intelligence for enterprise customers globally.
AI & Machine LearningCloud ComputingCybersecurity
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions. The company serves patients and healthcare providers worldwide across the neuroscience field.
BiotechHealthtechMedical DevicesCopenhagen, DK
Tagworks Pharmaceuticals develops a controlled drug-release technology platform using click chemistry to enable targeted activation of antibody-drug conjugates and immunomodulators in tumors. The company aims to expand ADC therapy options for cancer patients by targeting non-internalizing receptors and improving therapeutic efficacy.
BiotechMedical DevicesNijmegen, NL
Frequently asked questions
- What stage does Ysios Capital invest at?
- Ysios Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Ysios Capital focus on?
- Ysios Capital focuses on Biotech.
- Where is Ysios Capital located?
- Ysios Capital is headquartered in Denmark, DK.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.